GPC1 and pancreatic neoplasm: It was also enriched on serum-derivedEVs relative to unfractionated serum (30).When compared with healthy controls, glypican-1 was significantly increased in serumexosomes inpatients with pancreatic cancer, and research suggested it could be usedfor early detection of the disease with very high diagnostic sensitivity andspecificity (126).